Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis

Heparin thromboprophylaxis is routinely administered during hospitalization for COVID-19. Because of the immune stimulation related to COVID-19, there is ongoing concern regarding a heightened incidence of heparin-induced thrombocytopenia (HIT). We performed a literature search using PubMed, EMBASE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Uaprasert, Noppacharn, Tangcheewinsirikul, Nuanrat, Rojnuckarin, Ponlapat, Patell, Rushad, Zwicker, Jeffrey I., Chiasakul, Thita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455241/
https://www.ncbi.nlm.nih.gov/pubmed/34543382
http://dx.doi.org/10.1182/bloodadvances.2021005314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455241/
https://www.ncbi.nlm.nih.gov/pubmed/34543382
http://dx.doi.org/10.1182/bloodadvances.2021005314

Ejemplares similares